Tiziana says last patient completed last visit in phase 2A trial
Tiziana Life Sciences said the last patient completed the last visit in its Phase 2A Inform-MS trial of intranasal foralumab.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.